Mucormycosis complicating diabetes mellitus and COVID-19: a diagnostic and therapeutic threat

<p class="abstract">COVID-19 infections is known to have a multitude of clinical presentations, and newer complications continue be reported from all over the world. It now widely that diabetic patients with poor glycemic control are associated higher risk developing severe COVID-19 infection. They also at high for secondary bacterial or fungal, co because complex interplay multiple factors , necessitating an intensive medical care monitoring in them. We presenting case mucormycosis patient moderate COVID pneumonia presented us as orbital cellulitis events followed. There been very few documented cases infected so far during this pandemic we present literature review same.</p>